Detalhe da pesquisa
1.
C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro.
Acta Pharmacol Sin
; 39(4): 649-658, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29219946
2.
Vibsanin B preferentially targets HSP90ß, inhibits interstitial leukocyte migration, and ameliorates experimental autoimmune encephalomyelitis.
J Immunol
; 194(9): 4489-97, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25810397
3.
FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation.
Mol Cancer
; 13: 150, 2014 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927996
4.
The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK.
Nat Chem Biol
; 8(11): 897-904, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22983157
5.
A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro.
Cancer Res
; 70(9): 3628-37, 2010 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20388790